{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:58:19Z","timestamp":1790377099440,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.psyneuen.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T16:31:34Z","timestamp":1499272294000},"page":"143-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Neurotrophic and inflammatory markers in bipolar disorder: A prospective study"],"prefix":"10.1016","volume":"84","author":[{"given":"Seline","family":"van den Ameele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violette","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Schuermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"De Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Sabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Morrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2017.07.003_bib0005","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0010","first-page":"S36","article-title":"From neuroprogression to neuroprotection: implications for clinical care","volume":"193","author":"Berk","year":"2010","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psyneuen.2010.07.013","article-title":"Determinants of serum brain-derived neurotrophic factor","volume":"36","author":"Bus","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","article-title":"Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes","volume":"398","author":"Cunha","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2011.02.054","article-title":"Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study","volume":"494","author":"de Sousa","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/172460080101600202","article-title":"Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments","volume":"16","author":"Dittadi","year":"2001","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0045","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jad.2015.08.036","article-title":"Peripheral inflammation during abnormal mood states in bipolar I disorder","volume":"187","author":"Fiedorowicz","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0050","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jad.2013.06.055","article-title":"VEGF plasma level variations in duloxetine-treated patients with major depression","volume":"151","author":"Fornaro","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","article-title":"Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force","volume":"47","author":"Frey","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4306\/pi.2010.7.4.243","article-title":"The role of BDNF as a mediator of neuroplasticity in bipolar disorder","volume":"7","author":"Grande","year":"2010","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.physbeh.2011.10.029","article-title":"Mediators of allostasis and systemic toxicity in bipolar disorder","volume":"106","author":"Grande","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2012.04.044","article-title":"Evidence for an association between tumor necrosis factor-alpha levels and lithium response","volume":"143","author":"Guloksuz","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbi.2014.03.016","article-title":"Neuroinflammation in bipolar disorder \u2013 a [(11)C]-(R)-PK11195 positron emission tomography study","volume":"40","author":"Haarman","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1021379811308","article-title":"A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?","volume":"19","author":"Hormbrey","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-0327(97)00180-8","article-title":"Positive and negative acute phase proteins in affective subtypes","volume":"49","author":"Hornig","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0095","unstructured":"JMP Pro 12.0.1. SAS Institute, Cary, North Carolina, 2015."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","article-title":"Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder \u2212 results from a prospective study","volume":"197","author":"Jacoby","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant'Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hup.1215","article-title":"Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder","volume":"26","author":"Kikuchi","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jad.2011.07.021","article-title":"Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders","volume":"136","author":"Lee","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psychres.2015.04.020","article-title":"Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment","volume":"228","author":"Lee","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jagp.2016.09.009","article-title":"Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables","volume":"25","author":"Lee","year":"2017","journal-title":"Am. J. Geriatric Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2015.12.001","article-title":"Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: a preliminary study","volume":"170","author":"Lizano","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lfs.2015.02.010","article-title":"Angiogenesis in the pathophysiology of schizophrenia\u2014a comprehensive review and a conceptual hypothesis","volume":"128","author":"Lopes","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biopsych.2006.03.070","article-title":"Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode","volume":"61","author":"Machado-Vieira","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0165","doi-asserted-by":"crossref","first-page":"e48046","DOI":"10.1371\/journal.pone.0048046","article-title":"Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight","volume":"7","author":"Molendijk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0170","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.psyneuen.2014.05.011","article-title":"Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients","volume":"47","author":"Munkholm","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/mp.2015.54","article-title":"Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis","volume":"21","author":"Munkholm","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.it.2004.02.001","article-title":"Seasonal immune function and sickness responses","volume":"25","author":"Nelson","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0190","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbi.2009.04.005","article-title":"To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers","volume":"23","author":"O\u2019Connor","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0195","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dominguez","year":"2007","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.psyneuen.2017.07.003_bib0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bdi.12291","article-title":"Five-year outcome of bipolar I and II disorders: findings of the Jorvi Bipolar Study","volume":"17","author":"Pallaskorpi","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jad.2014.11.044","article-title":"BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis","volume":"174","author":"Polyakova","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.psyneuen.2017.07.003_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Progress Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0215","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz de Almodovar","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pnpbp.2014.08.013","article-title":"The role of neurotrophins in bipolar disorder","volume":"56","author":"Scola","year":"2015","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.02.067","article-title":"Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: a comprehensive review of human studies","volume":"197","author":"Sharma","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 20","key":"10.1016\/j.psyneuen.2017.07.003_bib0230","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis","volume":"7","author":"Suliman","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-9255-7-29","article-title":"Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients","volume":"7","author":"Tanni","year":"2010","journal-title":"J. Inflamm. (London, England)"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2009.01.028","article-title":"Brain-derived neurotrophic factor serum levels before and after treatment for acute mania","volume":"452","author":"Tramontina","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0250","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jad.2016.06.016","article-title":"The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: a systematic review","volume":"203","author":"van den Ameele","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0255","series-title":"Guide to Assessment Scales in Bipolar Disorder","author":"Vieta","year":"2009"},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry J. Mental Sci."},{"key":"10.1016\/j.psyneuen.2017.07.003_bib0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","article-title":"Severity classification on the hamilton depression rating scale","volume":"150","author":"Zimmerman","year":"2013","journal-title":"J. Affect. Disord."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453017303736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453017303736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:58:21Z","timestamp":1759683501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453017303736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":53,"alternative-id":["S0306453017303736"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.07.003","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurotrophic and inflammatory markers in bipolar disorder: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}